We studied the mechanism of the collagen type XI inhibitory effect in CAFs by analyzing the signaling pathways of collagen receptors, integrin α2β1, integrin α11β1 and DDR2, expressed in NSCLC CAFs. The gene discussed is ITGA2; the disease is non-small cell lung carcinoma.